Clinical Trial Update: To Evaluate the Treatment Effect of an Anti-Infective Agent for Complicated Infections (0826-053) [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating an anti-infective agent for complicated infections in sepsis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sepsis

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Sepsis | Phase 3 | Status: COMPLETED